Low-dose CT scan for pancreatic cancer screening
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study uses artificial intelligence to analyze low-dose CT scans of the abdomen to detect early signs of pancreatic cancer. It may help find cancer before symptoms appear.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older.
- You are willing to sign a consent form.
- You have already had a low-dose CT scan of your abdomen.
- You have never had pancreatic cancer.
- You have not had pancreatitis or other abdominal inflammation in the last 6 months.
- Your CT scan images are clear and not affected by fluid in the belly, injury to the pancreas, or recent surgery or radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to analyze routine CT scans of the chest or abdomen (done for other reasons) to detect early signs of pancreatic cancer. If you are already getting a CT scan for another health issue, this could help catch pancreatic cancer early without extra tests.
This study uses artificial intelligence (AI) to help doctors make better decisions for people with suspected pancreatic conditions. If you are already getting a special CT scan, the AI will analyze the images to see if it can improve diagnosis and treatment planning.
This trial uses an artificial-intelligence tool to help detect pancreatic cancer earlier and track people at higher risk. You may be asked to complete questionnaires and have imaging tests like MRI or CT to see how well the approach works.
This study is testing a computer program called PANDA that looks at routine CT scans of the chest or belly to check the pancreas. If you have already had a CT scan that includes your pancreas and it was a clear picture, you may be able to help improve this AI tool.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.